CAS 1123838-51-6

Glesatinib hydrochloride

CAS : 1123838-51-6

Glesatinib hydrochloride is a small-molecule kinase inhibitor, specifically targeting the MET, RON, and AXL receptor tyrosine kinases. This compound is synthesized chemically, showcasing specificity towards pathways implicated in various malignancies. The mode of action involves competitively inhibiting ATP binding, which is critical for the phosphorylation and activation of downstream signaling pathways that promote cell proliferation, survival, and metastasis. By impeding these pathways, Glesatinib hydrochloride effectively hampers the growth and spread of cancer cells.

Formule : C₃₁H₂₈ClF₂N₅O₃S₂

Degré de pureté : Min. 95%

Masse moléculaire : 656.17 g/mol

Ref: 3D-YUB83851

Glesatinib hydrochloride

CAS : 1123838-51-6

Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO.

Formule : C₃₁H₂₈ClF₂N₅O₃S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 656.16

Ref: TM-T15383